Cifenline

Cifenline

SCHEMBL28086532

CCNCC(O)c1cccc(O)c1.c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1F O60840 1/20 0.55
AR P10275 1/20 0.55
PDE4A P27815 1/20 0.55
SCN1A P35498 1/20 0.55
SCN4A P35499 1/20 0.55
SCN7A Q01118 1/20 0.55
CACNA1D Q01668 1/20 0.55
KCNH2 Q12809 1/20 0.55
CACNA1S Q13698 1/20 0.55
CACNA1C Q13936 1/20 0.55
SCN5A Q14524 1/20 0.55
SCN9A Q15858 1/20 0.55
SCN2A Q99250 1/20 0.55
SCN3A Q9NY46 1/20 0.55
SCN11A Q9UI33 1/20 0.55
SCN8A Q9UQD0 1/20 0.55
SCN10A Q9Y5Y9 1/20 0.55
LMNA P02545 3/20 0.53
HIF1A Q16665 3/20 0.53
GALR3 O60755 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cifenline SCHEMBL23712274 0.74 CACNA1F (1.00) CACNA1FARPDE4ASCN1ASCN4A
Cifenline SCHEMBL122806 0.74 CACNA1F (1.00) CACNA1FARPDE4ASCN1ASCN4A
Cifenline SCHEMBL23712302 0.74 CACNA1F (1.00) CACNA1FARPDE4ASCN1ASCN4A
Etilefrine SCHEMBL30510958 0.73 HIF1A (1.00) LMNAHIF1AGALR3SLC16A3MEN1
Etilefrine SCHEMBL150802 0.73 HIF1A (1.00) LMNAHIF1AGALR3SLC16A3MEN1
Etilefrine SCHEMBL29603739 0.73 HIF1A (1.00) LMNAHIF1AGALR3SLC16A3MEN1
Etilefrine SCHEMBL31204243 0.71 HIF1A (0.97) LMNAHIF1AGALR3SLC16A3MEN1
Etilefrine SCHEMBL207591 0.71 HIF1A (0.97) LMNAHIF1AGALR3SLC16A3MEN1
Cifenline SCHEMBL121044 0.70 CACNA1F (0.79) CACNA1FARPDE4ASCN1ASCN4A
Etilefrine SCHEMBL10753730 0.67 HIF1A (0.78) LMNAHIF1AGALR3SLC16A3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed